- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –

- Full data from Phase 3 TRANSCEND study underscore potential efficacy of…Read More

You might also be interested in reading Blue Owl Capital Q2 2025 Earnings Preview.